ArticleInflammopharmacology2025

Sunitinib treatment reduces proinflammatory cytokine levels and mortality rates by suppressing the NLRP3 inflammasome signaling pathway in sepsis.

Ahmet Kucuk et al.PubMed ↗Publisher ↗

No numbers read from the abstract.